Transethnic Transferability of a Genome-Wide Polygenic Score for Coronary Artery Disease

Affiliations

• ¹ Centre for Genomic Medicine, Department of Medicine (A.C.F., A.V.K.), Massachusetts General Hospital.
• ² Division of Cardiology, Department of Medicine (A.C.F., K.G.A., P.T.E., S.K., A.V.K.), Massachusetts General Hospital.
• ³ Department of Medicine, Harvard Medical School, Boston (A.C.F., K.G.A., P.T.E., S.K., A.V.K.).
• ⁴ Cardiovascular Disease Initiative (A.C.F., K.G.A., P.T.E., A.V.K.), Broad Institute of MIT and Harvard, Cambridge, MA.
• ⁵ Program in Medical and Population Genetics (A.C.F., K.G.A., P.T.E., S.K., A.V.K.), Broad Institute of MIT and Harvard, Cambridge, MA.
• ⁶ Department of Population Medicine, College of Medicine, QU Health, Qatar University, Doha (G.H.).
• ⁷ The Institute for Translational Genomics and Population Sciences, Department of Pediatrics, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Centre, Torrance, CA (Y.-D.I.C., J.I.R.).
• ⁸ Department of Genetics and Genomic Sciences, Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY (K.C., A.D., J.C., R.D.).
• ⁹ Section of Cardiovascular Medicine and the Robert Wood Johnson Clinical Scholars Program, Department of Medicine, Yale University School of Medicine, New Haven, CT (H.M.K.).
• ¹⁰ Department of Medicine, Taichung Veterans General Hospital, School of Medicine, National Yang-Ming University, Taipei, Taiwan (W.H.H.S.).
• ¹¹ Centre for Public Health Genomics, School of Medicine, University of Virginia, Charlottesville (S.S.R.).
• ¹² Department of Public Health and Primary Care, University of Cambridge, United Kingdom (R.C.).
• ¹³ Verve Therapeutics, Cambridge, MA (S.K.).